Navigation Links
Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
Date:8/5/2013

CARLSBAD, Calif., Aug. 5, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that patients treated with ISIS-CRPRx achieved rapid, dose-dependent mean reductions of up to 67 percent in C-reactive protein (CRP) in a Phase 2 study in patients with rheumatoid arthritis (RA).  Patients treated with ISIS-CRPRx showed improvements in signs and symptoms of RA; however, these improvements were not statistically significant when compared to those observed in patients in the placebo group, which demonstrated a higher than expected response in both symptom score and CRP reduction.  A Phase 2 study of ISIS-CRPRx in patients with atrial fibrillation is currently ongoing with data anticipated in the first half of 2014.

"CRP is strongly associated with the presence and severity of many diseases, including numerous inflammatory and cardiovascular diseases.  In this study, by treating patients with chronically elevated CRP with ISIS-CRPRx, we hoped to accomplish three things:  to confirm in patients the substantial CRP-lowering activity we observed in our earlier clinical studies, to gain additional experience with the drug before testing it in more severe indications, and to evaluate whether lowering CRP correlates with an improvement in RA symptoms.  The study accomplished its goals.  We are pleased with the consistency of CRP lowering across all of our clinical studies, but we are disappointed that we did not see a greater impact on RA symptoms in these patients," said Richard Geary, Ph.D., senior vice president of development at Isis.  "While we do not plan to further develop ISIS-CRPRx for RA, we do plan to continue to evaluate ISIS-CRPRx to treat other diseases."

The Phase 2 study was a randomized, place
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference
2. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
3. GW Pharmaceuticals plc Reports 2013 Third Quarter Financial Results
4. AcelRx Pharmaceuticals to Hold Second Quarter 2013 Financial Results Conference Call and Webcast on August 12, 2013
5. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018
6. OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.
7. Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2013 Financial Results
8. Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
9. Cadence Pharmaceuticals Reports Second Quarter 2013 Financial Results
10. Arisaph Pharmaceuticals Awarded Phase I STTR Grant To Develop Small Molecule Immune Modulators
11. Avion Pharmaceuticals, LLC, receives top accolades for trade and marketing achievements at the 11th Annual American Business Awards (The "Stevie Awards")
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... Mass. , May 29, 2015  Hologic, Inc. ... has entered into a new, five-year secured credit agreement ... a $1 billion revolving credit facility. Hologic ... and used these proceeds and the Term Loan to ... which had an aggregate principal amount outstanding of $1.69 ...
(Date:5/29/2015)... 29, 2015  Today, UL LLC, a global ... provider of electronic quality management systems (EQMS) and ... will leverage the strengths of both organizations to ... implementation and comprehensive advice and guidance for successful ... capabilities to UL,s strength in regulatory services and ...
(Date:5/29/2015)... Fla. , May 29, 2015  Excite Medical ... in 2007.  Over the years, Excite Medical, under the ... be an enduring company, with a solid track record ... and growing client and distributor base.  ... success of Excite Medical has been possible, in large ...
Breaking Medicine Technology:Hologic Enters into Five-Year Secured Credit Agreement 2Hologic Enters into Five-Year Secured Credit Agreement 3UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 2UL and MasterControl collaborate to provide medical manufacturers full service QMS and Regulatory Submissions support 3
... Conatus Pharmaceuticals Inc. today announced the closing of ... financing.  This financing was led by new investor, AgeChem ... existing investors; Aberdare Ventures, Advent Venture Partners, Bay City ... will use the proceeds to advance the clinical development ...
... Mindray Medical International Limited (NYSE: MR), a leading developer, ... that it will report its financial results for the ... market closes on February 28, 2011. Mindray,s management will ... March 1, 2011 U.S. Eastern Time (9:00 PM on ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Mindray to Report Fourth Quarter and Full Year 2010 Financial Results on February 28, 2011 2
(Date:5/29/2015)... Ready to hit the road? Before embarking on a big ... vehicles ready. With handicapped vehicles, there are even more things ... ready to help drivers get their handicapped vans ready by ... When planning for the big trip, drivers should be sure ... smoothly and they are prepared for all contingencies: , ...
(Date:5/29/2015)... What does community do? , According ... comes together to plant gardens, to teach young people, ... of critical issues. Community invites everyone to help improve ... "What Community Does" was commissioned by The Denver Foundation, ... released during the foundation’s Annual Celebration in May. At ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The science ... in Los Angeles thanks to the efforts of internationally ... Mohebi has combined ARTAS hair restoration and ... hair restoration procedures available anywhere. , A Follicular ... and individually harvesting hair follicle grafts from the donor ...
(Date:5/29/2015)... M3 USA MDLinx.com, source of the “ ... now offers The Smartest Rheumatologist . The Smartest ... ranging from Fibromyalgia and Osteoporosis, to Arthritis and Gout. ... and Caroline Tredway, editorial head of The Smartest Doc ... on the physicians who participate. Says Tredway, “With so ...
(Date:5/29/2015)... Rhode Island (PRWEB) May 29, 2015 ... 7, 2015. The event, now closed to new registration, ... Fort Adams. This exciting competitive running event demonstrates ... organizations to create a public benefit – in this ... scenic coastal views around the famed Ocean Drive and ...
Breaking Medicine News(10 mins):Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:What Community Does: A New Video from The Denver Foundation 2Health News:Los Angeles and Beverly Hills Hair Transplant Doctor Now Combines Robotic Hair Restoration (ARTAS) and Manual FUE Transplants for Maximum Hair Coverage 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3
... drug) treatment that can be applied directly to site of ... osteoarthritis pain * Voltaren Gel is the only prescription ... ... the hands * Offers highly effective pain relief with minimal drug absorption, throughout ...
... Adopts InterviewDirect to ... Positions, CHERRY HILL, N.J., Oct. 22 ... telephone-based job candidate screening solutions,today announced that ... InterviewDirect service to pre-qualify job candidates for ...
... and MCLEAN, Va., Oct. 22 Science,Applications International ... it,signed an agreement with the University of Kent ... to collaborate on biometric and,identity projects. Fostered ... (UKTI), the agreement,aims to maximize cooperation from academia, ...
... done in part by researchers at The University of ... discovery of two genes that cause ankylosing spondylitis, an ... published in the Oct. 21 online edition of Nature ... basis for common and complex diseases. , John D. ...
... for elderly patients with lung cancer has changed little ... treatment. The study by Harvard University, National Cancer Institute, ... the December 1, 2007 issue of CANCER, a peer-reviewed ... life-expectancy rose by less than one month between 1983 ...
... can keep vision, other injuries at bay, experts say , , ... can help ensure that Halloween is a treat for both ... America, a nonprofit organization based in Chicago. , "We can ... precautions," Daniel D. Garrett, the group,s senior vice president, said ...
Cached Medicine News:Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 2Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 3Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 4Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 5Health News:Voltaren(R) Gel Receives US Regulatory Approval as the First Approved Topical Prescription Treatment for Pain Associated with Osteoarthritis 6Health News:Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates 2Health News:Albert Einstein Healthcare Network Turns to InterviewDirect to Qualify Job Candidates 3Health News:SAIC to Collaborate with UK Biometrics Institute 2Health News:SAIC to Collaborate with UK Biometrics Institute 3Health News:UT rheumatologists discover 2 genes related to disabling form of arthritis 2Health News:UT rheumatologists discover 2 genes related to disabling form of arthritis 3Health News:Spending more for lung cancer treatment did not substantially increase patients' lives 2Health News:Eye on Safety Makes Halloween Less Scary 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: